申请人:Ciba-Geigy Corporation
公开号:US04410530A1
公开(公告)日:1983-10-18
Heterocyclic compounds of the formula ##STR1## wherein Het denotes optionally substituted pyridazinyl, pyrimidinyl, pyrazinyl or substituted pyridyl, R.sub.1 is hydrogen or methyl and R.sub.2 is lower alklyl, optionally substituted phenyl-lower alkyl, carboxy-lower alkyl or functionally modified carboxy-lower alkyl, their condensation products with aldehydes, ketones or carbonic acid and their N-oxides, which are valuable (cardioselective) .beta.-receptor blocking agents, and/or (cardioselective) .beta.-receptor-stimulants.
式为##STR1##的杂环化合物,其中Het表示可选择地取代的吡啶啉基、嘧啶基、吡嗪基或取代的吡啶基,R.sub.1为氢或甲基,R.sub.2为低碳链基、可选择地取代的苯基-低碳链基、羧基-低碳链基或功能性改性的羧基-低碳链基,它们与醛、酮或碳酸的缩合产物以及它们的N-氧化物,是有价值的(心脏选择性的)β-受体阻滞剂和/或(心脏选择性的)β-受体激动剂。